Back to FDA Applications sponsored by ACTELION PHARMS LTD

FDA Drug Application 021779 by ACTELION PHARMS LTD

Application Number021779
Application Type New Drug Application
Most Recent Label Available Flag
Current Patent Flag
Action Type Approval
Chemical Type New molecular entity (NME)
Therapeutic Potential Priority
Orphan CodeV

Action TypeDuplicate CounterAction DateDocument TypeApplication Document IDSequence NumberDocument TitleDocument URLDocument Date
AP012/29/2004N10918000 1/11/2005
AP012/29/2004N10942000 1/11/2005
AP012/29/2004N11290000 3/28/2005
AP08/24/2005SE112670001,002ltr.pdf 8/31/2005
AP08/24/2005SE112688001,002lbl.pdf 8/31/2005
AP08/24/2005SCF12689002,002lbl.pdf 8/31/2005
AP08/24/2005SCF12671002,002ltr.pdf 8/31/2005
AP012/8/2005SCS13256003 12/15/2005
AP012/8/2005SCS13269003 12/15/2005
AP03/4/2008SLR19358006 3/5/2008
AP03/4/2008SLR19397006 3/7/2008
AP09/22/2008SLR20875008 9/23/2008
AP09/22/2008SLR20882008 9/25/2008
AP08/7/2009SCM23436009 9/22/2009
AP08/7/2009SCM24650009 1/27/2010
AP08/7/2009SCM30818009 10/10/2011
AP04/20/2010SLR25338010 4/23/2010
AP04/20/2010SLR25436010 5/3/2010
AP02/8/2011SLR27801012 2/9/2011
AP02/8/2011SLR27827012 2/14/2011
AP04/26/2012SLR32574013 5/1/2012
AP04/26/2012SLR32584013 5/2/2012
AP011/22/2013SLR37906014 11/25/2013
AP011/22/2013SLR37933014 11/26/2013

Back to FDA Applications sponsored by ACTELION PHARMS LTD

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer

Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.